Journal article · 2025 · Open access

Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications

Karrar Najeh Chfat, Shaker Awad Abdul Hussein

Pharmakeftiki · Published 10 October 2025

Open PDFView at the publisherCite this paper

In brief

“Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications” is a 2025 journal article by Karrar Najeh Chfat and Shaker Awad Abdul Hussein, published in Pharmakeftiki. OpenAlex counts 0 citations as of 19 November 2026. It is open access: the full text is free to read at Pharmakeftiki.

Citations
0
References
6
Authors
2

Abstract

Beyond conventional small-molecule inhibitors, proteolysis-targeting chimeras (PROTACs) represent a novel therapeutic strategy for targeted protein degradation. These heterobifunctional molecules are engineered in order to recruit an E3 ubiquitin ligase to a specific protein of interest, thereby facilitating its ubiquitination and subsequent degradation by the proteasome. This approach has garnered significant attention due to its ability to target proteins traditionally considered “undruggable”, including those lacking enzymatic activity or accessible binding pockets. This mini-review outlines the mechanistic basis of PROTACs, key design principles, and recent advances in the field. Particular emphasis is placed on the potential of PROTACs to address persistent challenges in drug discovery, notably the need for selective elimination of pathogenic proteins. The review also explores strategies for optimizing PROTAC-based therapies and discusses current limitations, such as pharmacokinetic constraints and the need for improved E3 ligase engagement. Owing to their distinctive mode of action and expanding therapeutic scope, PROTACs hold promise for transforming the treatment landscape of cancer, neurological disorders, and other diseases driven by aberrant protein expression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chfat, K. N., & Hussein, S. A. A. (2025). Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications. Pharmakeftiki. https://pharmakeftiki.hsmc.gr/pj/article/view/275

MLA 9

Chfat, Karrar Najeh, and Shaker Awad Abdul Hussein. “Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications.” Pharmakeftiki, 2025. https://pharmakeftiki.hsmc.gr/pj/article/view/275.

Chicago

Chfat, Karrar Najeh and Shaker Awad Abdul Hussein. 2025. “Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications.” Pharmakeftiki. https://pharmakeftiki.hsmc.gr/pj/article/view/275.

Harvard

Chfat, K. N. and Hussein, S. A. A. (2025) ‘Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications’, Pharmakeftiki. Available at: https://pharmakeftiki.hsmc.gr/pj/article/view/275.

IEEE

K. N. Chfat and S. A. A. Hussein, “Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications,” Pharmakeftiki, 2025.

BibTeX

@article{chfat2025proteolysis,
  title     = {{Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications}},
  author    = {Chfat, Karrar Najeh and Hussein, Shaker Awad Abdul},
  journal   = {Pharmakeftiki},
  year      = {2025},
  url       = {https://pharmakeftiki.hsmc.gr/pj/article/view/275}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • targeted protein degradation
  • E3 ubiquitin ligase
  • heterobifunctional molecules
  • ubiquitination
  • proteasome
  • undruggable proteins
  • PROTAC design

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Chfat, K. N., & Hussein, S. A. A. (2025). Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications. Pharmakeftiki. https://pharmakeftiki.hsmc.gr/pj/article/view/275

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmakeftiki: sign in and open the PDF from this page.

Who wrote this paper?

Karrar Najeh Chfat, Shaker Awad Abdul Hussein.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.